Enhanced post-marketing surveillance of the COVID-19 vaccines in aotearoa New Zealand.
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: RSC-005
- By: HANLON, Timothy (Ministry of Health New Zealand, New Zealand)
- Co-author(s): Dr Timothy Hanlon, Group Manager (Ministry of Health New Zealand, Wellington, New Zealand)
Ms Muireann Walton, Senior Advisor (Ministry of Health New Zealand, Wellington, New Zealand)
Ms Mariana Traslosheros Reyes, Advisor (Ministry of Health New Zealand, Wellington, New Zealand)
Title: Enhanced Post-Marketing Surveillance of the COVID-19 vaccines in Aotearoa New Zealand.
Background: The post-marketing surveillance of medicines and vaccines in New Zealand has been traditionally delivered using a spontaneous reporting system by Medsafe, the medicines regulator, and the Centre for Adverse Reactions Monitoring (CARM), part of .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.